跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 37 条关于
“ENKTL”
全部
37
临床试验
28
药物
0
机构
0
资讯
9
3个月前
VT-EBV-N Shows 95% Durable Disease-Free Survival in EBV-Positive ENKTL: Phase II Data at EHA 2026
去年
Antengene to Present Selinexor Data from Two Late-Stage Studies at ASH 2024
去年
Antengene to Present Selinexor Data from Phase III Multiple Myeloma and Phase I/II Lymphoma Studies at ASH 2024
去年
Antengene to Present Selinexor Data in Relapsed/Refractory Multiple Myeloma and Extranodal NK/T-Cell Lymphoma at ASH 2024
去年
Antengene to Present Selinexor Data from Late-Stage Trials at ASH 2024
去年
Sintilimab/Chidamide Combination Shows Promising Results in Early-Stage Natural Killer T-Cell Lymphoma
去年
Antengene's Selinexor Shows Promise in Multiple Myeloma and Lymphoma Studies
2个月前
CStone Strikes Oceania Deal with Arrotex for Anti-PD-L1 Antibody Sugemalimab
去年
Chugai Receives Japanese Approval for Tecentriq in Rare Lymphoma, Marking First Checkpoint Inhibitor for ENKL